HomeUSAForesee Genomics Raises $1.3M in SAFE Financing

Foresee Genomics Raises $1.3M in SAFE Financing

-

Margalit Tocher, CEO of Foresee Genomics
Margalit Tocher, CEO of Foresee Genomics

Foresee Genomics, a San Francisco, CA-based next generation sequencing (NGS) solutions company focused on the small and medium-sized laboratory market, raised $1.3M in SAFE (Simple Agreement for Future Equity) Financing.

GoodPaper Ventures provided the financing.

The company intends to use the funds to expand operations and its development efforts. This marks its final pre-revenue fundraising effort, setting the stage for the commencement of product sales in the United States later this year.

Led by CEO Margalit Tocher, and CTO and Founder Dr. Roi Feingersch, Foresee Genomics develops comprehensive solutions, including protocols, reagents, and bioinformatics tools, to make NGS accessible to small and medium-sized laboratories. Its aims to enable these labs to perform high-accuracy genomic analysis independently, without the need for costly infrastructure or high minimum quantities.

By streamlining the sequencing workflow and optimizing per-sample costs, the company helps laboratories provide insights that support personalized patient care.

Since its founding in 2019, Foresee Genomics has spearheaded three clinical trials and pilot initiatives, two in Israel and one in the United States, and is now preparing for its commercial launch.

FinSMEs

29/01/2025

THE DAILY NEWSLETTER - SIGNUP